Fluocinolone acetonide

Fluocinolone acetonide is filed as Corticosteroid [EPC]. The sections below restate public label fields stored for this profile.

Class
Corticosteroid [EPC]
Route
TOPICAL
Dosage forms
Cataract formation: Nearly all phakic patients are expected to develop cataracts and require cataract surgery. (5.1) Endophthalmitis: Late onset endophthalmitis has been observed. (5.2) Increase in intraocular pressure: Use of corticosteroids may result in elevated IOP and/or glaucoma. (5.3) IOP lowering medications were required in > 75% of patients; filtering surgeries were required in > 35% of patients. (6.1) Separation of implant components: Physicians should periodically monitor the integrity of the implant by visual inspection. (5.4)
Generic available
Yes
Manufacturer
Sun Pharmaceutical Industries, Inc.

Approved uses

INDICATIONS AND USAGE Fluocinolone Acetonide Topical Solution is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

How it works

CLINICAL PHARMACOLOGY Topical corticosteroids share anti-inflammatory, anti-pruritic and vasoconstrictive actions. The mechanism of anti-inflammatory activity of the topical corticosteroids is unclear. Various laboratory methods, including vasoconstrictor assays, are used to compare and predict potencies and/or clinical efficacies of the topical corticosteroids. There is some evidence to suggest that a recognizable correlation exists between vasoconstrictor potency and therapeutic efficacy in man. Pharmacokinetics The extent of percutaneous absorption of topical corticosteroids is determined by many factors including the vehicle, the integrity of the epidermal barrier, and the use of occlusive dressings. Topical corticosteroids can be absorbed from normal intact skin. Inflammation and/or other disease processes in the skin increase percutaneous absorption. Occlusive dressings substantially increase the percutaneous absorption of topical corticosteroids. Thus, occlusive dressings may be a valuable therapeutic adjunct for treatment of resistant dermatoses (see DOSAGE AND ADMINISTRATION ) . Once absorbed through the skin, topical corticosteroids are handled through pharmacokinetic pathways similar to systemically administered corticosteroids. Corticosteroids are bound to plasma proteins in varying degrees. Corticosteroids are metabolized primarily in the liver and are then excreted by the kidneys. Some of the topical corticosteroids and their metabolites are also excreted into the bile.

Contraindications

CONTRAINDICATIONS Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Adverse reactions

ADVERSE REACTIONS The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: Burning Perioral dermatitis Itching Allergic contact dermatitis Irritation Maceration of the skin Dryness Secondary infection Folliculitis Skin atrophy Hypertrichosis Striae Acneiform eruptions Miliaria Hypopigmentation

Dosage and administration

DOSAGE AND ADMINISTRATION Fluocinolone Acetonide Solution is generally applied to the affected area as a thin film from two to four times daily depending on the severity of the condition. In hairy sites, the hair should be parted to allow direct contact with the lesion. Occlusive dressing may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.

Common questions

What is Fluocinolone acetonide approved to treat?

According to its FDA label, Fluocinolone acetonide is approved for: INDICATIONS AND USAGE Fluocinolone Acetonide Topical Solution is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. For medical advice, please talk to your prescriber or pharmacist.

What class of drug is Fluocinolone acetonide?

Fluocinolone acetonide belongs to the Corticosteroid [EPC] class of medications.

What form does Fluocinolone acetonide come in?

The FDA label lists Fluocinolone acetonide as: Cataract formation: Nearly all phakic patients are expected to develop cataracts and require cataract surgery. (5.1) Endophthalmitis: Late onset endophthalmitis has been observed. (5.2) Increase in intraocular pressure: Use of corticosteroids may result in elevated IOP and/or glaucoma. (5.3) IOP lowering medications were required in > 75% of patients; filtering surgeries were required in > 35% of patients. (6.1) Separation of implant components: Physicians should periodically monitor the integrity of the implant by visual inspection. (5.4); topical route. Available strengths and packaging vary by manufacturer.

Is there a generic version of Fluocinolone acetonide?

Yes. A generic version of Fluocinolone acetonide is available in the U.S. Ask your pharmacist about substitution.

Does Fluocinolone acetonide have a Boxed Warning?

Our ingest of the FDA label for Fluocinolone acetonide does not include a Boxed Warning at this time. See the full label on DailyMed for the current, authoritative version.

How much does Fluocinolone acetonide cost?

Public CMS NADAC pricing for Fluocinolone acetonide is in the range Retail prices vary widely by pharmacy, insurance, and location. Check with your pharmacy or use tools like GoodRx for current pricing.. Retail price varies by pharmacy, insurance, and manufacturer coupons.

Is Fluocinolone acetonide currently under recall?

The FDA Enforcement Report does not show an active/ongoing recall for Fluocinolone acetonide in our latest ingest. Recall data can change daily — verify at FDA.gov.

When was Fluocinolone acetonide approved by the FDA?

The FDA record lists the approval date for Fluocinolone acetonide as 1985-09-11.

Who makes Fluocinolone acetonide?

The FDA label lists Sun Pharmaceutical Industries, Inc. as a labeler/manufacturer of Fluocinolone acetonide. Multiple firms may market generics of the same molecule.

How should Fluocinolone acetonide be stored?

The FDA label states: "STORAGE Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Avoid excessive heat. Protect from freezing." Follow the packaging insert for the authoritative guidance.

On this site

Related medications in this class or category

Loading full data from Know Your Drugs Institute…